Pharma & Biotech

The biotechnology sector faces renewed scrutiny as Iovance Biotherapeutics experiences significant market pressure. Disappointing quarterly performance and emerging class action...

The healthcare sector is witnessing a notable divergence in performance, with Johnson & Johnson emerging as a standout performer. While...

NuCana shares experienced a severe downturn during the latest trading session, recording double-digit percentage losses that rattled market participants. The...

The investment case for biotechnology firm Incyte has become a subject of intense debate among financial experts, with prominent research...

Despite posting consistent losses and witnessing significant insider selling, Denali Therapeutics is capturing intense market interest. The biotech firm's shares,...

Cellectar Biosciences shares are experiencing significant downward pressure in the wake of a recently completed financing arrangement. Despite successfully securing...

Assembly Biosciences finds itself at the center of a classic Wall Street debate, with prominent research firms issuing starkly conflicting...

The shares of Arvinas are exhibiting notable volatility today, trading at $9.65 with a gain of 0.68%. Underpinning this price...

IO Biotech shares continue to experience extreme price swings following a critical regulatory development. The catalyst for this volatility was...

Clearside Biomedical has successfully navigated the threat of delisting from the Nasdaq exchange, marking a critical milestone for the biotechnology...